Diabetes, Vol 46, Issue 10 1633-1636, Copyright © 1997 by American Diabetes Association

ARTICLES

Beta 3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients

N Sakane, T Yoshida, K Yoshioka, Y Nakamura, T Umekawa, A Kogure, Y Takakura and M Kondo
First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Japan.

Proliferative diabetic retinopathy is an important cause of visual impairment. We investigated whether the polymorphism of the beta 3-adrenoreceptor (beta 3-AR) gene, which is associated with insulin resistance and an earlier onset of NIDDM, was associated with proliferative diabetic retinopathy (PDR) in 215 Japanese NIDDM patients with a duration of diabetes of > or = 10 years. The polymorphism of the beta 3-AR gene was determined by polymerase chain reaction-restriction fragment length polymorphism analysis. The Trp64Arg allele of the beta 3-AR gene was significantly more frequent in the NIDDM patients with PDR (P = 0.002), but not in those with non-PDR (P = 0.151), than in NIDDM patients without diabetic retinopathy. Those with the mutation had an earlier onset of diabetes, a longer duration of diabetes, and higher current and maximal BMI values, compared with those without the mutation. Moreover, this mutation was also associated with higher serum triglyceride and decreased HDL-cholesterol levels. When adjustment was made for age, age at diagnosis, duration of diabetes, current BMI, systolic blood pressure, HbA1e, and serum lipids in a multiple regression analysis, a significant association was found between the Trp64Arg allele and diabetic retinopathy (P = 0.039). The Arg/Arg or Arg/Trp genotype was significantly associated with PDR, compared with the Trp/Trp genotype, with an odds ratio of 2.55 (95% CI 1.25-5.16). We concluded that the beta 3-AR gene polymorphism is a newly identified risk factor for PDR.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Kotani, N. Sakane, Y. Kurozawa, A. Kaetsu, M. Okamoto, Y. Osaki, and T. Kishimoto Polymorphism of Trp64Arg in {beta}3-adrenergic receptor gene and serum LDL-cholesterol concentrations in healthy Japanese Ann Clin Biochem, May 1, 2008; 45(3): 313 - 315. [Abstract] [Full Text] [PDF]

				T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe, K. Inukai, I. Inoue, and S. Katayama A Common Polymorphism in the 5'-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes Diabetes, May 1, 2002; 51(5): 1635 - 1639. [Abstract] [Full Text] [PDF]

				N. Dzimiri Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502. [Abstract] [Full Text] [PDF]

				T. Fujisawa, H. Ikegami, Y. Kawaguchi, and T. Ogihara Meta-Analysis of the Association of Trp64Arg Polymorphism of {beta}3-Adrenergic Receptor Gene with Body Mass Index J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2441 - 2444. [Abstract] [Full Text]